期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细胞色素氧化酶CYP1A2的研究进展 被引量：36

Advance in cytochrome P450 1A2
下载PDF
导出
摘要 CYP1A2是一种重要的细胞色素P450酶,可代谢多种临床常用药物,并参与活化许多前毒物和前致癌物。CYP1A2酶活性可受到基因多态性、药物、饮食等因素的影响,其中基因多态性是导致CYP1A2活性及可诱导性产生个体差异的基础,对CYP1A2基因多态性的鉴定分型在个体化用药中具有重要的指导意义。 CYP1 A2 is an important cytochrome P450 enzymes, which is involved in metabolism of many clinical drugs and activation of some precarcinogens. CYP1 A2 activity can be influenced by various factors including genetic polymorphism, drugs, food and so on, in which the CYP1 A2 genetic polymorphism is the basis of difference on the activity and induction of CYP1A2. Therefore, the genotyping of CYP1 A2 plays an important part in individualization of therapy.
作者 肖鹏 周宏灏
机构地区 中南大学临床药理研究所
出处 《中南大学学报（医学版）》 CAS CSCD 北大核心 2008年第5期456-460,共5页 Journal of Central South University ：Medical Science
关键词 CYP1A2 药物代谢 遗传多态性 CYP1 A2 drug metabolism genetic polymorphism
分类号 Q55 [生物学—生物化学]
  • 相关文献

参考文献24

  • 1Nelson D R, Zeldin D C, Hoffman S M, et al. Comparison of cytochrome P450 ( CYP ) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and ahernative- splice variants [ J ] . Pharmacogenetics, 2004,14(1) :1-18.
  • 2Ikeya K,Jaiswal A K,Owens R A,et al. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1 A2 mRNA expression [ J ]. Mol Endocrinol , 1989,3 ( 9 ) : 1399-1408.
  • 3Quattrochi L C, Vu T, Tukey R H. The human CYPIA2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction [ J ]. J Biol Chem, 1994, 269 (9) : 6949- 6954.
  • 4Chung I, Bresnick E. Regulation of the constitutive expression of the human CYPIA2 gene: cis elements and their interactions with proteins [J]. Mol Pharmacol, 1995,47 (4) : 677-685
  • 5Pickwell G V, Shih H, Quattrochi L C. Interaction of upstream stimulatory factor proteins with an E- box located within the human CYP1A2 5'-flanking gene contributes to basal transcriptional gene activation [ J ]. Biochem Pharmacol, 2003,65(7) :1087-1096.
  • 6Chung I, Bresnick E. Identification of positive and negative regulatory elements of the human cytochrome P4501 A2 (CYP1A2) gene[J]. Arch Biochem Biophys ,1997 ,338 (2) :220-226.
  • 7Soyama A, Saito Y, Hanioka N, et al. Single nucleotide polymorphisms and haplotypes of CYP1 A2 in a Japanese population[J]. Drug Metab Pharmacokinet,2005,20(1) :24- 33.
  • 8Faber M S, Jetter A, Fuhr U. Assessment of CYP1 A2 activity in clinical practice: why,how,and when? [J]. Basic Clin Pharmacol Toxicol, 2005, 97(3): 125 - 134.
  • 9Nakajima M, Yokoi T, Mizutani M, et al. Genetic polymorphism in the 5 '-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans[ J]. J Biochem (Tokyo) ,1999,125(4) :803-808.
  • 10Han X M,Ou-Yang D S,Lu P X,et al. Plasma caffeine metabolite ratio ( 17 X / 137 X ) in vivo associated with G- 2964A and C734A polymorphisms of human CYP1A2 [J]. Pharmacogenetics,2001,11(5) :429-435.

二级参考文献1

共引文献4

同被引文献415

引证文献36

二级引证文献112

中南大学学报（医学版）
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部